Evidence map›Paper›PMID 41578382›Full record

ArticleBiology direct2026

Robust SH2 binding affinity indicates minimal SH3-to-SH2 communication in Grb2.

Eduarda Santos Ventura, Mariana Di Felice, Julian Toso, Valeria Pennacchietti, Angelo Toto, Stefano Gianni

Abstract read
In one paragraph

Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eduarda Santos Ventura *Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy.
Mariana Di Felice *Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy.
Julian TosoDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy.
Valeria PennacchiettiDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy.
Angelo TotoDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy.
Stefano GianniDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, 00185, Italy. stefano.gianni@uniroma1.it.

Funding

Associazione Italiana per la Ricerca sul Cancro IG 24451
6 · The paper itself

Abstract

Growth factor receptor–bound protein 2 (Grb2) is a modular adaptor that links activated receptor tyrosine kinases to downstream signaling pathways through its SH3–SH2–SH3 architecture. Previous studies showed that perturbations in the SH2 domain can influence ligand binding at the C-terminal SH3 domain, suggesting directional allosteric communication within the protein. Here, we tested whether the flanking SH3 domains, in turn, modulate SH2-mediated ligand recognition. Using a parallel mutational scan of the isolated SH2 domain and full-length Grb2, combined with stopped-flow kinetics and double-mutant-cycle analysis, we found that SH2 binding energetics remain essentially unchanged in the presence of the SH3 domains. Only three of twenty-one variants displayed measurable coupling, and none exceeded the threshold typically associated with significant allosteric effects. Pre-binding of the C-SH3 domain to a Gab2-derived peptide likewise produced no detectable influence on SH2–ligand binding. These results reveal a marked asymmetry in interdomain communication in Grb2 and show that the SH2 domain functions as a robust, largely autonomous module within the full-length protein.

Indexed as

GRB2 Adaptor Proteinsrc Homology DomainsHumansKineticsProtein BindingGRB2 Adaptor ProteinGRB2 protein, humanAdaptor proteinsAllosteryKineticsSite-directed mutagenesis

Identifiers

PMID41578382
PMCPMC12911276

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.